Clinical Trials · NCT04028323

Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)

Name: Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

UnknownPhase 4Octreotide

Phase: Phase 4
Recruitment status: Unknown
Sponsor: Nanfang Hospital, Southern Medical University
Enrollment: 60
Start date: Jul 2019
Locations: 10 sites, China
Primary endpoint: Renal function

View Octreotide compound reference